ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023
PORTLAND, Maine, Nov. 13, 2023 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, today announced its unaudited financial results for the quarter ended September 30, 2023.
Related news for (ICCC)
- ImmuCell Embarks on CEO Succession Planning Process
- ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders
- ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2025
- ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 of 2025
- ImmuCell Hires Chief Financial Officer